Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson’s Disease.
Beckley Retreats Launches Signature Program for Personal Discovery and Transformation | Psychedelic Invest
Beckley Retreats, a psilocybin retreats and holistic wellbeing company, announced today the launch of its Signature Program for Personal Discovery and Transformation, an 11-week curriculum